SIGA Technologies
American pharmaceutical / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about SIGA Technologies?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.[3][4][5][6]
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
Nasdaq: SIGA Russell 2000 Component | |
Industry | Healthcare Biotechnology Health security |
Founded | December 28, 1995 (1995-12-28)[1] |
Headquarters | , United States |
Key people | Diem Nguyen, Ph.D. (CEO) Dennis E. Hruby, Ph.D. (CSO) |
Products | Pharmaceutical agents |
Revenue | $133.7 million (2021) |
$89.1 million (2021) | |
$69.5 million (2021) | |
Number of employees | 39 (2022) |
Website | siga |
Footnotes / references [2] |
Close